Diagnostic methods for congestive heart failure
View Patent ↗The invention provides an assay for the quantification of circulating glycophorin in biological fluid samples. The circulating glycophorin measured by this assay is a truncated glycophorin diagnostic for congestive heart failure (CHF).
1. A method for determining whether a subject is suffering from congestive heart failure comprising:
analyzing a body fluid of the subject to detect a presence and concentration level of unbound and freely circulating truncated glycophorin in said body fluid,
correlating an elevated level of said truncated glycophorin with congestive heart failure.
2. The method of claim 1 , wherein the body fluid is blood plasma.
3. The method of claim 2 , wherein the blood plasma is substantially free of red blood cells.
4. The method of claim 1 , wherein the glycophorin comprises a circulating, truncated glycophorin.
5. A method for determining whether a subject is suffering from congestive heart failure comprising:
analyzing a body fluid of the subject to detect a presence and concentration level of an unbound and freely circulating truncated glycophorin recognized by monoclonal antibody 3F4(ATCC PTA-5154); and
correlating an elevated level of said truncated glycophorin with congestive heart failure.
6. The method of claim 5 , wherein said glycophorin is detected immunologically.
7. The method of claim 5 , wherein the sample is a plasma sample.